Zydus Cadila's jab will be the sixth COVID-19 vaccine to get approved in India after Covishield, Covaxin, Sputnik V, Moderna and J&J. Fulvestrant injection is used alone or in combination with ...

Swine flu or H1N1 virus infection has swept through the Delhi-NCR region as a survey says more than 50 per cent of households with at least one person is suffering from symptoms like high fever, sore ...

Under Patel's leadership, Zydus Lifesciences grew to become ... Patel is also involved in the development of a vaccine called Zycov-D to fight Covid. Pankaj Patel has received numerous awards ...

Zydus Lifesciences announced on Tuesday that it will develop a combination vaccine for shigellosis and typhoid. The company, with support from the Gates Foundation, will conduct early-stage ...

Viruses like SARS-CoV-2 use sugar molecules to hide from the immune system, but scientists at Scripps Research have designed ...

The National Institutes of Health, which falls under the jurisdiction of HHS, has terminated grants for research into vaccine ...

This new type of vaccine, which is based on the same technology as the Covid vaccines first developed by BioNTech and Moderna, is seen by many as a potential breakthrough in the fight against cancer.

Yale researchers have found clues as to why certain people experience adverse health effects after the COVID-19 vaccine, which they have dubbed “post-vaccination syndrome." ...